- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07581925
Detection of Systemic Diseases Such as Hepatobiliary Diseases From Ocular Images Via Deep Learning
May 11, 2026 updated by: Zhongshan Ophthalmic Center, Sun Yat-sen University
Oculomics is an emerging interdisciplinary field that deciphers multi-dimensional, high-throughput ocular data to predict, diagnose, and monitor systemic diseases and health span.In recent years, artificial Intelligence may provide insight into exploring the potential covert association behind and reveal some early ocular architecture changes in individuals with systemic diseases.
The investigators conducted a survey to explore the association between the eye and systemic diseases via deep learning, to develop and evaluate different deep learning models to predict the systemic diseases such as hepatobiliary disease by using ocular images.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
775
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Guangdong
-
Guangzhou, Guangdong, China, 510000
- Zhongshan Ophthalmic Center, Sun Yat-sen Univerisity
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Probability Sample
Study Population
ocular images collected from the Third Affiliated Hospital of Sun Yat-sen University and Pazhou Medical Centre of Aikang Health Care
Description
Inclusion Criteria:
- The quality of ocular images should clinical acceptable.
- Complete clinical information such as baseline demographic characteristics, the history of systematic diseases and so on.
Exclusion Criteria:
- Individuals diagnosed with severe eye diseases or acute systematic diseases.
- Incompatible with ocular examinations.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
development dataset 01
ocular images collected from the Third Affiliated Hospital of Sun Yat-sen University
|
The training dataset was used to train the deep learning model, which was validated and tested by the other two datasets.
|
|
development dataset 02
ocular images collected from Pazhou Medical Centre of Aikang Health Care
|
The training dataset was used to train the deep learning model, which was validated and tested by the other two datasets.
|
|
test dataset 01
ocular images collected from the Third Affiliated Hospital of Sun Yat-sen University
|
The training dataset was used to train the deep learning model, which was validated and tested by the other two datasets.
|
|
test dataset 02
ocular images collected from Pazhou Medical Centre of Aikang Health Care
|
The training dataset was used to train the deep learning model, which was validated and tested by the other two datasets.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
area under the receiver operating characteristic curve of the deep learning system
Time Frame: baseline
|
The investigators will calculate the area under the receiver operating characteristic curve of deep learning system and compare this index between deep learning system and human doctors
|
baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
sensitivity of the deep learning system
Time Frame: baseline
|
The investigators will calculate the sensitivity of deep learning system and compare this index between deep learning system and human doctors
|
baseline
|
|
specificity of the deep learning system
Time Frame: baseline
|
The investigators will calculate the specifity of deep learning system and compare this index between deep learning system and human doctors
|
baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 10, 2020
Primary Completion (Actual)
July 30, 2024
Study Completion (Actual)
July 30, 2024
Study Registration Dates
First Submitted
May 6, 2026
First Submitted That Met QC Criteria
May 6, 2026
First Posted (Actual)
May 12, 2026
Study Record Updates
Last Update Posted (Actual)
May 14, 2026
Last Update Submitted That Met QC Criteria
May 11, 2026
Last Verified
May 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2019KYPJ163
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Systemic Diseases
-
Beijing GoBroad HospitalCARsgen Therapeutics Co., Ltd.RecruitingSystemic Lupus Erythematosus (SLE) | Systemic Sclerosis (SSc)China
-
The Affiliated Hospital of Xuzhou Medical UniversityShanghai Xiniao Biotech Co., Ltd.Active, not recruitingSystemic Lupus Erythematosus | Systemic SclerosisChina
-
Shenzhen MagicRNA Biotechnology Co., LtdThe First Affiliated Hospital of University of Science and Technology of...Not yet recruitingSystemic Lupus Erythematosus | Autoimmune Disease | Systemic Sclerosis (SSc)China
-
LiveKidney.BioMedical University of South Carolina; Galilee CBRRecruitingSystemic Lupus Erythematosus | SLE | Systemic Lupus Erythematosus (SLE) | Lupus | Systemic Lupus ErthematosusUnited States
-
Hacettepe UniversityRecruitingScleroderma, Localized | Scleroderma | Systemic Sclerosis (SSc) | Scleroderma Systemic | Scleroderma (Limited and Diffuse) | Juvenile Systemic Sclerosis | Systemic Sclerosis - 2013 ACR/EULAR Classification CriteriaTurkey (Türkiye)
-
AmgenTerminatedDiffuse Cutaneous Systemic Sclerosis | Sclerosis, SystemicSpain, Japan, Romania, United States, Mexico, Argentina, Israel, Greece, Chile, Serbia, South Korea, Italy, Poland, Portugal, United Kingdom
-
Assiut UniversityNot yet recruitingSystemic Sclerosis and Systemic Lupus Erythematous
-
Fred Hutchinson Cancer CenterNational Institute of Allergy and Infectious Diseases (NIAID)CompletedSystemic Scleroderma | Severe Systemic SclerosisUnited States
-
University Hospital, BordeauxCompletedSystemic Lupus Erythematosus | Systemic SclerodermaFrance
-
AmgenTerminatedDiffuse Cutaneous Systemic Sclerosis | Sclerosis, SystemicSpain, Serbia